QSI Quantum-Si incorporated Stock Quote

QSI [NASD]

Index	-	P/E	-	EPS (ttm)	-0.25	Insider Own	16.40%	Shs Outstand	11.70M	Perf Week	0.23%
Market Cap	1.21B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	-	Perf Month	2.95%
Income	-3.60M	PEG	-	EPS next Q	-	Inst Own	41.30%	Short Float	-	Perf Quarter	-27.09%
Sales	-	P/S	-	EPS this Y	-	Inst Trans	17.15%	Short Ratio	4.31	Perf Half Y	-17.97%
Book/sh	43.09	P/B	0.20	EPS next Y	-	ROA	-1.70%	Target Price	-	Perf Year	-
Cash/sh	3.76	P/C	2.32	EPS next 5Y	-	ROE	-1.80%	52W Range	7.43 - 25.00	Perf YTD	-14.09%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-66.28%	Beta	-
Dividend %	-	Quick Ratio	66.60	Sales past 5Y	-	Gross Margin	-	52W Low	13.46%	ATR	0.45
Employees	112	Current Ratio	66.60	Sales Q/Q	-	Oper. Margin	-	RSI (14)	46.81	Volatility	5.71% 5.43%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-	Profit Margin	-	Rel Volume	0.44	Prev Close	8.72
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 16 AMC	Payout	-	Avg Volume	1.13M	Price	8.43
Recom	-	SMA20	-1.36%	SMA50	-3.54%	SMA200	-20.58%	Volume	487,194	Change	-3.33%

Oct-20-21

Initiated

Canaccord Genuity

Buy

$13

Oct-19-21 04:15PM	Quantum-Si Announces Expansion of Early Access Program for the Platinum Single Molecule Protein Sequencing Platform Business Wire
Sep-21-21 04:15PM	Quantum-Si Incorporated to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference Business Wire
Sep-13-21 11:26AM	What Type Of Shareholders Make Up Quantum-Si incorporated's (NASDAQ:QSI) Share Registry? Simply Wall St.
Aug-16-21 04:05PM	Quantum-Si Reports Second Quarter 2021 Financial Results Business Wire
Aug-11-21 07:00AM	Quantum-Si to Report Second Quarter 2021 Financial Results on August 16, 2021 Business Wire -5.78%
Jul-27-21 08:30AM	Quantum-Si to Report Second Quarter 2021 Financial Results on August 12, 2021 Business Wire -8.78%
Jun-24-21 04:05PM	Quantum-Si Signs Lease for Product Development and Operations Facility in San Diego Biotechnology Hub Business Wire

Quantum-Si incorporated operates first next-generation protein sequencing and genomics platform for healthcare industries. It offers a single molecule detection solution to decode the molecules of life, including sample preparation, single molecule, massively parallel, and protein identification. The company's technology has the applications in proteomics, single cell, transcriptomics, genomics, metabolomics, and drug testing and screening fields. The company is based in Guilford, Connecticut. Quantum-Si incorporated is a subsidiary of 4Catalyzer Corporation.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience